Volume 13, Number 11—November 2007
Perspective
Danish Integrated Antimicrobial Resistance Monitoring and Research Program
Anette M. Hammerum*
, Ole E. Heuer†, Hanne-Dorthe Emborg†, Line Bagger-Skjøt*, Vibeke F. Jensen†, Anne-Marie Rogues*, Robert L. Skov*, Yvonne Agersø†, Christian T. Brandt*, Anne Mette Seyfarth†, Arno Muller*, Karin Hovgaard‡, Justin Ajufo§, Flemming Bager†, Frank M. Aarestrup†, Niels Frimodt-Møller*, Henrik C. Wegener†, and Dominique L. Monnet*
, Ole E. Heuer†, Hanne-Dorthe Emborg†, Line Bagger-Skjøt*, Vibeke F. Jensen†, Anne-Marie Rogues*, Robert L. Skov*, Yvonne Agersø†, Christian T. Brandt*, Anne Mette Seyfarth†, Arno Muller*, Karin Hovgaard‡, Justin Ajufo§, Flemming Bager†, Frank M. Aarestrup†, Niels Frimodt-Møller*, Henrik C. Wegener†, and Dominique L. Monnet*
Figure 3
Figure 3. Trends in glycopeptide resistance among Enterococcus faecium from broiler chickens and pigs and the consumption of the growth promoter avoparcin in animals, Denmark, 1994–2005 (revised from 12).
Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.